| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000001031 |
| Receipt No. | R000001226 |
| Scientific Title | A long-term prospective cohort study on the natural course and effect of intervention in patients with hepatitis C virus infection. |
| Date of disclosure of the study information | 2008/03/31 |
| Last modified on | 2020/08/23 (Ver. 11) |
| Basic information | ||
| Public title | A long-term prospective cohort study on the natural course and effect of intervention in patients with hepatitis C virus infection. | |
| Acronym | A prospective cohort study in patients with hepatitis C virus infection. | |
| Scientific Title | A long-term prospective cohort study on the natural course and effect of intervention in patients with hepatitis C virus infection. | |
| Scientific Title:Acronym | A prospective cohort study in patients with hepatitis C virus infection. | |
| Region |
|
|
| Condition | ||
| Condition | Patients with hepatitis C virus infection. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the natural course and the efficacy and safety of medical intervention in patients with hepatitis C virus infection. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Death (liver related or unrelated). |
| Key secondary outcomes | 1. Development of hepatocellular carcinoma.
2. Progression to hepatic decompensation. 3. Progression to cirrhosis. 4. Achievement of sustained virological response. 5. Achievement of sustained biochemical response. 6. Adverse events, dose modification, and discontinuation of therapy. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with or with histry of hepatitis C virus infection. | |||
| Key exclusion criteria | None | |||
| Target sample size | 1500 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Okayama University Hospital | ||||||
| Division name | Department of Gastroenterology and Hepatology | ||||||
| Zip code | 700-8558 | ||||||
| Address | 2-5-1, Shikata-cho, Kita-ku, Okayama-city, Okayama, Japan | ||||||
| TEL | 086-235-7219 | ||||||
| yiwasaki@okayama-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Okayama University Hospital | ||||||
| Division name | Department of Gastroenterology and Hepatology | ||||||
| Zip code | 700-8558 | ||||||
| Address | 2-5-1, Shikata-cho, Kita-ku, Okayama-city, Okayama, Japan | ||||||
| TEL | 086-235-7219 | ||||||
| Homepage URL | |||||||
| yiwasaki@okayama-u.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Gastroenterology and Hepatology, Okayama University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Okayama University |
| Address | 2-5-1, Shikata-cho, Kita-ku, Okayama |
| Tel | 086-235-6938 |
| mae6605@adm.okayama-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Consecutively enrolled, prospective cohort study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000001226 |